News

Montara Therapeutics Closes $8 Million Seed Round to Develop Safer, More Effective Neuroscience Drugs Using a Novel Brain-Only Pharmacology Approach

Montara Therapeutics, a therapeutics company aiming to revolutionize the discovery and development of brain-targeting drugs, announced today the closing of an oversubscribed $8 million seed financing led by SV Health Investors’ Dementia Discovery Fund and co-lead Two Bear Capital. Dolby Family...

Linus Health Acquires Together Senior Health to Expand its Platform to Better Serve Patients and Providers with End-to-end Workflow Capabilities

Linus Health, a digital health company enabling early detection of cognitive impairment, Alzheimer’s, and other dementias, today announced its acquisition of Together Senior Health (Together), a brain health company delivering evidence-based solutions for individuals with cognitive decline,...

Exai Bio Appoints New Chief Executive Officer

Exai Bio, a next-generation oncRNA- and generative AI-based liquid biopsy company, today announced the appointment of Dave Daly as Chief Executive Officer. With more than 30 years of cancer diagnostics and executive leadership experience, including at Thrive Earlier Detection (acquired by Exact...

PreludeDx™ and Cancer Help Desk Announce Collaboration to Support Women Diagnosed with DCIS Breast Cancer

Prelude Corporation a breast cancer precision diagnostics company, and Cancer Help Desk, have partnered to provide expert nurse navigation services for women diagnosed with ductal carcinoma in situ (DCIS) breast cancer.

Rezo Therapeutics Appoints Cristiana Guiducci, Ph.D., as Chief Scientific Officer

Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, today announced the appointment of Cristiana Guiducci, Ph.D., as chief scientific officer. Dr. Guiducci previously served as senior vice president of immunology and oncology...

Fostering health AI development with confidential computing

In 2020, the University of California, San Francisco (UCSF) Center for Digital Health Innovation (CDHI), Fortanix, Intel, and Microsoft Azure formed a collaboration to create a privacy-preserving confidential computing platform to accelerate clinical algorithm development and validation.

Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer base

Illumina, a global leader in DNA sequencing and array-based technologies, announced that effective today it has acquired Fluent BioSciences, developer of an emerging and highly differentiated single-cell technology.   More

Chroma Medicine Announces Exclusive License Agreement with the Whitehead Institute for Novel Epigenetic Editing Technology

Chroma Medicine, a genomic medicine company pioneering single-course epigenetic editing therapeutics, today announced it has entered into an exclusive license agreement with the Whitehead Institute to access intellectual property and technology developed in the lab of Chroma co-founder Jonathan...

How Space Research Helps Fight Infection and Aging Back on Earth

When an unmanned NASA spacecraft landed in Fort Lauderdale, Florida, a few days before Christmas 2023, its payload included liver cells from UC San Francisco that had spent two months orbiting Earth on the International Space Station. Physician-researcher Sonja Schrepfer, MD, PhD, sent the cells to...

Neurona Therapeutics Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for NRTX-1001 in Focal Epilepsy

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that the U.S Food and Drug Administration (FDA) has granted the company’s lead product candidate, NRTX-1001, the RMAT expedited program...